Importance of glial activation in neuropathic pain

European Journal of Pharmacology

Volumn 716, Issue 1-3, 2013, Pages 106-119

  Mika, Joanna ^a   Zychowska, Magdalena ^a   Popiolek Barczyk, Katarzyna ^a   Rojewska, Ewelina ^a   Przewlocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Astroglia; Glial inhibitors; Microglia; Neuropathic pain; Opioids

Indexed keywords

CATHEPSIN S; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; FLUOROCITRIC ACID; FRACTALKINE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; MORPHINE; PENTOXIFYLLINE; PROPENTOFYLLINE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANALGESIA; CELL ACTIVATION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; DRUG TOLERABILITY; GLIA; HUMAN; MACROGLIA; MICROGLIA; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ASTROGLIA; GLIAL INHIBITORS; MICROGLIA; NEUROPATHIC PAIN; OPIOIDS;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; MORPHINE; NEURALGIA; NEUROGLIA;

EID: 84892530761     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.01.072     Document Type: Review

References (232)

1. Adler, J.E., Nico, L., VandeVord, P., Skoff, A.M., 2009. Modulation of neuropathic pain by a glial-derived factor. Pain Med. 10, 1229-1236.
2. Adler, M.W., Geller, E.B., Chen, X., Rogers, T.J., 2006. Viewing chemokines as a third major system of communication in the brain. Review. AAPS J. 7, E865-E870.
3. Aloisi, F., 2001. Immune function of microglia. Glia 36, 165-179.
4. Alshekhlee, A., Basiri, K., Miles, J.D., Ahmad, S.A., Katirji, B., 2010. Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists. Muscle Nerve 41, 723-727.
5. Alten, R., Gram, H., Joosten, L.A., van den Berg, W.B., Sieper, J., Wassenberg, S., Burmester, G., van Riel, P., Diaz-Lorente, M., Bruin, G.J., Woodworth, T.G., Rordorf, C., Batard, Y., Wright, A.M., Jung, T., 2008. The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res. Ther. 10, R67.
6. Amin, A.R., Attur, M.G., Thakker, G.D., Patel, P.D., Vyas, P.R., Patel, R.N., Patel, I.R., Abramson, S.B., 1996. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Nat. Acad. Sci. U.S.A. 93, 14014-14019.
7. Armitage, R.J., Macduff, B.M., Eisenman, J., Paxton, R., Grabstein, K.H., 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154, 483-490.
8. Aronson, A.L., 1980. Pharmacotherapeutics of the newer tetracyclines. J. Am. Vet. Med. Assoc. 176, 1061-1068.
9. Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A., Karin, M., 1995. Immuno-suppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286-290.
10. Austin, P.J., Moalem-Taylor, G., 2010. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol. 229, 26-50.
11. Badolato, R., Ponzi, A.N., Millesimo, M., Notarangelo, L.D., Musso, T., 1997. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood 90, 2804-2809.
12. Benveniste, E.N., Tang, L.P., Law, R.M., 1995. Differential regulation of astrocyte TNF-alpha expression by the cytokinesTGF-beta, IL-6 and IL-10. Int. J. Dev. Neurosci. 13, 341-349.
13. Bettoni, I., Comelli, F., Rossini, C., Granucci, F., Giagnoni, G., Peri, F., Costa, B., 2008. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia 56, 1312-1319.
14. Boddeke, E.W., 2001. Involvement of chemokines in pain. Eur. J. Pharmacol. 429, 115-119.
15. Burmester, G.R., Feist, E., Kellner, H., Braun, J., Iking-Konert, C., Rubbert-Roth, A., 2011. Effectiveness and safety of the interleukin 6-receptor antagonist tocili-zumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA). Ann. Rheum. Dis. 70, 755-759.
16. Campbell, R.D., Law, S.K., Reid, K.B., Sim, R.B., 1988. Structure, organization, and regulation of the complement genes. Annu. Rev. Immunol. 6, 161-195.
17. Cata, J.P., Weng, H.R., Dougherty, P.M., 2008. Spinal injection of IL-2 or IL-15 alters mechanical and thermal withdrawal thresholds in rats. Neurosci. Lett. 437, 45-49.
18. Chen, J., Zhang, J., Zhao, Y., Yuan, L., Nie, X., Li, J., Ma, Z., Zhang, Y.,Wang, Q., Chen, Y., Jin, Y., Rao, Z., 2007. Hyperalgesia in response to traumatic occlusion and GFAP expression in rat parabrachial [correction of parabranchial] nucleus: modulation with fluorocitrate. Cell Tissue Res. 329, 231-237.
19. Chen, J., Liao, N., Lai, S., Hsu, L., Mao, W., Ku, M., Liao, F., 2005. Reduced 2, 4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor α-deficient mice correlates with diminished CCL5/RANTES and CXCL10/P-10 expression. Eur. J. Immunol. 35, 690-698.
20. Chang, V., McCurdy, D., Gordon, L.K., 2007. Etanercept associated optic neuropathy. Clin. Experiment. Ophthalmologica 35, 680-682.
21. Chen, Z.Y., Patel, P.D., Sant, G., Meng, C.X., Teng, K.K., Hempstead, B.L., Lee, F.S., 2004. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 24, 4401-4411.
22. Clark, A.K., Gentry, C., Bradbury, E.J., McMahon, S.B., Malcangio, M., 2007a. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain 11, 223-230.
23. Clark, A.K., Yip, P.K., Grist, J., Gentry, C., Staniland, A.A., Marchand, F., Dehvari, M., Wotherspoon, G., Winter, J., Ullah, J., Bevan, S., Malcangio, M., 2007b. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Nat. Acad. Sci. U.S.A. 104, 10655-10660.
24. Colburn, R.W., Rickman, A.J., DeLeo, J.A., 1999. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp. Neurol. 157, 289-304.
25. Colburn, R.W., DeLeo, J.A., Rickman, A.J., Yeager, M.P., Kwon, P., Hickey, W.F., 1997. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J. Neuroimmunol. 79, 163-175.
26. Colovic, M., Caccia, S., 2003. Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat. Life Sci. 791, 337-343.
27. Costigan, M., Moss, A., Latremoliere, A., Johnston, C., Verma-Gandhu, M., Herbert, T. A., Barrett, L., Brenner, G.J., Vardeh, D., Woolf, C.J., Fitzgerald, M., 2009. T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J. Neurosci. 29, 14415-14422.
28. Coyle, D.E., 1998. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 23, 75-83.
29. Cunha, F.Q., Poole, S., Lorenzetti, B.B., Veiga, F.H., Ferreira, S.H., 1999. Cytokinemediated inflammatory hyperalgesia limited by interleukin-4. Br. J. Pharmacol. 126, 45-50.
30. DeLeo, J.A., Tanga, F.Y., Tawfik, V.L., 2004. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 10, 40-52.
31. DeLeo, J.A., Yezierski, R.P., 2001. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90, 1-6.
32. DeLeo, J.A., Colburn, R.W., Nichols, M., Malhotra, A., 1996. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 16, 695-700.
33. Deumens, R., Jaken, R.J., Knaepen, L., van der Meulen, I., Joosten, E.A., 2009. Inverse relation between intensity of GFAP expression in the substantia gelatinosa and degree of chronic mechanical allodynia. Neurosci. Lett. 452, 101-105.
34. Di Meglio, P., Ianaro, A., Ghosh, S., 2005. Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation. Arthritis Rheum. 52, 951-958.
35. Dirig, D.M., Yaksh, T.L., 1999. Spinal synthesis and release of prostanoids after peripheral injury and inflammation. Adv. Exp. Med. Biol. 469, 401-408.
36. Dobrogowski, J., Kus, M., Sedlak, K.,Wordliczek, J., 1996. Ból i jego leczenie. Springer PWN, Warszawa.
37. Dobrogowski, J., Wrzosek, A., Wordliczek, J., 2005. Radiofrequency denervation with or without addition of pentoxifylline or methylprednisolone for chronic lumbar zygapophysial joint pain. Pharmacol. Rep. 57, 475-480.
38. Dominguez, E., Rivat, C., Pommier, B., Mauborgne, A., Pohl, M., 2008. JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J. Neurochem. 107, 50-60.
39. Dorazil-Dudzik, M., Mika, J., Schafer, M.K., Li, Y., Obara, I.,Wordliczek, J., Przewlocka, B., 2004. The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in the inflamed tissue of the rat paw. Anesth. Analg. 98, 1566-1573.
40. Dreger, M., Mika, J., Bieller, A., Jahnel, R., Gillen, C., Schafer, M.K., Weihe, E., Hucho, F., 2005. Analysis of the dorsal spinal cord synaptic architecture by combined proteome analysis and in situ hybridization. J. Proteome. Res. 4, 238-249.
41. Duan, S., Anderson, C.M., Keung, E.C., Chen, Y., Swanson, R.A., 2003. P2×7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci. 23, 1320-1328.
42. Dubovy, P., Jancalek, R., Klusakova, I., Svizenska, I., Pejchalova, K., 2006. Intra- and extraneuronal changes of immunofluorescence staining for TNF-alpha and TNFR1 in the dorsal root ganglia of rat peripheral neuropathic pain models. Cell. Mol. Neurobiol. 26, 1205-1217.
43. Dworkin, R.H., O'Connor, A.B., Audette, J., Baron, R., Gourlay, G.K., Haanpää, M.L., Kent, J.L., Krane, E.J., Lebel, A.A., Levy, R.M., Mackey, S.C., Mayer, J., Miaskowski, C., Raja, S.N., Rice, A.S., Schmader, K.E., Stacey, B., Stanos, S., Treede, R.D., Turk, D.C., Walco, G.A., Wells, C.D., 2010. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Review. Mayo Clin. Proc. 85, 3-14.
44. Ehrentraut, H., Weber, C., Ehrentraut, S., Schwederski, M., Boehm, O., Knuefermann, P., Meyer, R., Baumgarten, G., 2011. The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy. Eur. J. Heart Fail. 13, 602-610.
45. Eriksson, N.P., Persson, J.K., Svensson, M., Arvidsson, J., Molander, C., Aldskogius, H., 1993. A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat. Exp. Brain Res. 96, 19-27.
46. Faivre, A., Franques, J., De Paula, A.M., Gutierrez, M., Bret, S., Aubert, S., Attarian, S., Pouget, J., 2010. Acute motor and sensory axonal neuropathy and concomitant encephalopathy during tumor necrosis factor-alpha antagonist therapy. J. Neurol. Sci. 291, 103-106.
47. Flatters, S.J., Fox, A.J., Dickenson, A.H., 2003. Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy. Brain Res. 984, 54-62.
48. Fujiki, M., Zhang, Z., Guth, L., Steward, O., 1996. Genetic influences on cellular reactions to spinal cord injury: activation of macrophages/microglia and astrocytes is delayed in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration. J. Comp. Neurol. 371, 469-484.
49. Furst, D.E., 2004. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin. Ther. 26, 1960-1975.
50. Gao, Y.J., Ji, R.R., 2010. Targeting astrocyte signaling for chronic pain. Review. Neurotherapeutics 7, 482-493.
51. Gardell, L.R., Wang, R., Ehrenfels, C., Ossipov, M.H., Rossomando, A.J., Miller, S., Buckley, C., Cai, A.K., Tse, A., Foley, S.F., Gong, B., Walus, L., Carmillo, P., Worley, D., Huang, C., Engber, T., Pepinsky, B., Cate, R.L., Vanderah, T.W., Lai, J., Sah, D.W., Porreca, F., 2003. Multiple actions of systemic artemin in experimental neuropathy. Nat. Med. 9, 1383-1389.
52. Garrison, C.J., Dougherty, P.M., Kajander, K.C., Carlton, S.M., 1991. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res. 565, 1-7.
53. Genevay, S., Stingelin, S., Gabay, C., 2004. Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study. Ann. Rheum. Dis. 63, 1120-1123.
54. George, A., Marziniak, M., Schafers, M., Toyka, K.V., Sommer, C., 2000. Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain 88, 267-275.
55. Ghilardi, J.R., Svensson, C.I., Rogers, S.D., Yaksh, T.L., Mantyh, P.W., 2004. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. J. Neurosci. 24, 2727-2732.
56. Giulian, D., Baker, T.J., Shih, L.C., Lachman, L.B., 1986. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164, 594-604.
57. Goldsmith, S.K., Wals, P., Rozovsky, I., Morgan, T.E., Finch, C.E., 1997. Kainic acid and decorticating lesions stimulate the synthesis of C1q protein in adult rat brain. J. Neurochem. 68, 2046-2052.
58. Gomez-Nicola, D., Valle-Argos, B., Suardiaz, M., Taylor, J.S., Nieto-Sampedro, M., 2008. Role of IL-15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T-cell infiltration. J. Neurochem. 107, 1741-1752.
59. Griffin, R.S., Costigan, M., Brenner, G.J., Ma, C.H., Scholz, J., Moss, A., Allchorne, A.J., Stahl, G.L., Woolf, C.J., 2007. Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J. Neurosci. 27, 8699-8708.
60. Gruol, D.L., Nelson, T.E., 1997. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15, 307-339.
61. Guo, J., Jia, D., Jin, B., Xu, F., Yuan, X., Shen, H., 2012. Effects of glial cell line-derived neurotrophic factor intrathecal injection on spinal dorsal horn glial fibrillary acidic protein expression in a rat model of neuropathic pain. Int. J. Neurosci. 122, 388-394.
62. Haber, M., Zhou, L., Murai, K.K., 2006. Cooperative astrocyte and dendritic spine dynamics at hippocampal excitatory synapses. J. Neurosci. 26, 8881-8891.
63. Hains, B.C., Waxman, S.G., 2006. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 26, 4308-4317.
64. Hao, S., Mata, M., Glorioso, J.C., Fink, D.J., 2006. HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol. Pain 2, 1-6.
65. Hopkins, S.J., Rothwell, N.J., 1995. Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci. 18, 83-88.
66. Huang, J., Kim, L.J., Mealey, R., Marsh, H.C., Zhang, Y., Tenner, A.J., Connolly, E.S., Pinsky, D.J., 1999. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285, 595-599.
67. Hutchinson, M.R., Coats, B.D., Lewis, S.S., Zhang, Y., Sprunger, D.B., Rezvani, N., Baker, E. M., Jekich, B.M., Wieseler, J.L., Somogyi, A.A.,Martin, D., Poole, S., Judd, C.M.,Maier, S. F.,Watkins, L.R., 2008. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav. Immunol. 22, 1178-1189.
68. Ignatowski, T.A., Covey, W.C., Knight, P.R., Severin, C.M., Nickola, T.J., Spengler, R.N., 1999. Brain-derived TNFalpha mediates neuropathic pain. Brain Res. 841, 70-77.
69. Jancalek, R., Dubovy, P., Svizenska, I., Klusakova, I., 2010. Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerve. J. Neuroinflamm. 7, 1-11.
70. Ji, H.,Wang, H., Zhang, F., Li, X., Xiang, L., Aiguo, S., 2010. PPARγ agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways. Inflamm. Res. 59, 921-929.
71. Ji, R.R., Suter, M.R., 2007. p38 MAPK, microglial signaling, and neuropathic pain. Review. Mol. Pain 1, 3-33.
72. Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M.J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., Okabe, K., Ohya, K., Ghosh, S., 2004. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. 10, 617-624.
73. Jin, S.X., Yin, K.S., Bian, T., Sun, P.L., 2006. Imiquimod attenuates airway inflammation and decreases the expression of thymus and activation regulated chemokine in allergic asthmatic mice. Chin. Med. J. 119, 412-416.
74. Jin, S.X., Zhuang, Z.Y.,Woolf, C.J., Ji, R.R., 2003. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017-4022.
75. Johnston, I.N., Milligan, E.D., Wieseler-Frank, J., Frank, M.G., Zapata, V., Campisi, J., Langer, S., Martin, D., Green, P., Fleshner, M., Leinwand, L., Maier, S.F., Watkins, L.R., 2004. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci. 24, 7353-7365.
76. Johnson, S.A., Pasinetti, G.M., Finch, C.E., 1994. Expression of complement C1qB and C4 mRNAs during rat brain development. Brain Res. Dev. Brain Res. 80, 163-174.
77. Kalso, E., Edwards, J.E., Moore, R.A., McQuay, H.J., 2004. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Review. Pain 112, 372-380.
78. Kato, K., Liu, H., Kikuchi, S., Myers, R.R., Shubayev, V.I., 2010. Immediate anti-tumor necrosis factor-alpha (etanercept) therapy enhances axonal regeneration after sciatic nerve crush. J. Neurosci. Res. 88, 360-368.
79. Katsura, H., Obata, K., Mizushima, T., Sakurai, J., Kobayashi, K., Yamanaka, H., Dai, Y., Fukuoka, T., Sakagami, M., Noguchi, K., 2006. Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J. Neurosci. 26, 8680-8690.
80. Kawasaki, A., Hoshino, K., Osaki, R., Mizushima, Y., Yano, S., 1992. Effect of ibudilast: a novel antiasthmatic agent, on airway hypersensitivity in bronchial asthma. J. Asthma 29, 245-252.
81. Kawasaki, Y., Xu, Z.Z., Wang, X., Park, J.Y., Zhuang, Z.Y., Tan, P.H., Gao, Y.J., Roy, K., Corfas, G., Lo, E.H., Ji, R.R., 2008. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat. Med. 14, 331-336.
82. Kishi, Y., Ohta, S., Kasuya, N., Sakita, S., Ashikaga, T., Isobe, M., 2001. Ibudilast: a non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall. Cardiovasc. Drug Rev. 19, 215-225.
83. Kreutzberg, G.W., 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
84. Lan, L., Yuan, H., Duan, L., Cao, R., Gao, B., Shen, J., Xiong, Y., Chen, L.W., Rao, Z.R., 2007. Blocking the glial function suppresses subcutaneous formalin-induced nociceptive behavior in the rat. Neurosci. Res. 57, 112-119.
85. Lawrance, I.C., Wu, F., Leite, A.Z., Willis, J., West, G.A., Fiocchi, C., Chakravarti, S., 2003. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology 125, 1750-1761.
86. Ledeboer, A., Hutchinson, M.R., Watkins, L.R., Johnson, K.W., 2007a. Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin. Invest. Drugs 16, 935-950.
87. Ledeboer, A., Jekich, B.M., Sloane, E.M., Mahoney, J.H., Langer, S.J., Milligan, E.D., Martin, D., Maier, S.F., Johnson, K.W., Leinwand, L.A., Chavez, R.A., Watkins, L.R., 2007b. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav. Immun. 21, 686-698.
88. Ledeboer, A., Sloane, E.M., Milligan, E.D., Frank, M.G., Mahony, J.H., Maier, S.F.,Watkins, L.R., 2005. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115, 71-83.
89. Lee, K.M., Jeon, S.M., Cho, H.J., 2010. Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK. Eur. J. Pain 14, 682 e1-682.e12.
90. Lee, H.L., Lee, K.M., Son, S.J., Hwang, S.H., Cho, H.J., 2004. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 15, 2807-2811.
91. Leger, T., Grist, J., D'Acquisto, F., Clark, A.K., Malcangio, M., 2011. Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells. J. Neuroimmunol. 234, 19-26.
92. Liu, J.S., John, G.R., Sikora, A., Lee, S.C., Brosnan, C.F., 2000. Modulation of interleukin-1beta and tumor necrosis factor alpha signaling by P2 purinergic receptors in human fetal astrocytes. J. Neurosci. 20, 5292-5299.
93. Liu, L., Tornqvist, E., Mattsson, P., Eriksson, N.P., Persson, J.K., Morgan, B.P., Aldskogius, H., Svensson, M., 1995. Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat. Neuroscience 68, 167-179.
94. Lord, C.J., Lamb, J.R., 1996. TH2 cells in allergic inflammation: a target of immunotherapy. Clin. Exp. Allergy 26, 756-765.
95. Lu, C.H., Chao, P.C., Borel, C.O., Yang, C., Yeh, C.C.,Wong, C.S.,Wu, C.T., 2004. Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery. Anesth. Analg. 99, 1465-1471.
96. Lundblad, R., Ekstrom, P., Giercksky, K.E., 1995. Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Shock 3, 210-215.
97. Machelska, H., Ziolkowska, B., Mika, J., Przewlocka, B., Przewlocki, R., 1997. Chronic morphine increases biosynthesis of nitric oxide synthase in the rat spinal cord. Neuroreport 8, 2743-2747.
98. Malcangio, M., Bowery, N.G., Flower, R.J., Perretti, M., 1996. Effect of interleukin-1 beta on the release of substance P from rat isolated spinal cord. Eur. J. Pharmacol. 299, 113-118.
99. Mao, J., Sung, B., Ji, R.R., Lim, G., 2002. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 22, 8312-8323.
100. Marchand, F., Tsantoulas, C., Singh, D., Grist, J., Clark, A.K., Bradbury, E.J., McMahon, S.B., 2009. Effects of Etanercept and Minocycline in a rat model of spinal cord injury. Eur. J. Pain 13, 673-681.
101. Marchand, F., Perretti, M., McMahon, S.B., 2005. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 6, 521-532.
102. Mayer, D.J., Mao, J., Holt, J., Price, D.D., 1999. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc. Nat. Acad. Sci. U.S.A. 96, 7731-7736.
103. McMahon, S.B., Cafferty, W.B., Marchand, F., 2005. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444-462.
104. McMahon, S.B., 2002. Neuropathic Pain Mechanisms. In: Pain 2002-an updated review. pp. 155-164.
105. Meunier, A., Latrémoličre, A., Dominguez, E., Mauborgne, A., Philippe, S., Hamon, M., Mallet, J., Benoliel, J.J., Pohl, M., 2007. Lentiviral-mediated Targeted NF-κB Blockade in Dorsal Spinal Cord Glia Attenuates Sciatic Nerve Injury-induced Neuropathic Pain in the Rat. Mol. Ther. 15, 687-697.
106. Mika, J., Obara, I., Przewlocka, B., 2011. The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction. Neuropeptides 45, 247-261.
107. Mika, J., Rojewska, E., Makuch, W., Przewlocka, B., 2010. Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in DRG in rat model of neuropathic pain. Neuroscience 165, 1420-1428.
108. Mika, J., Wawrzczak-Bargiela, A., Osikowicz, M., Makuch, W., Przewlocka, B., 2009a. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain, Behav. Immun. 23, 75-84.
109. Mika, J., Osikowicz, M., Rojewska, E., Korostynski, M., Wawrzczak-Bargiela, A., Przewlocki, R., Przewlocka, B., 2009b. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur. J. Pharmacol. 623, 65-72.
110. Mika, J., 2008a. Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. Review. Pharmacol. Rep. 60, 297-307.
111. Mika, J., 2008b. The opioid systems and the role of glial cells in the effects of opioids. Adv. Pall Med. 7, 185-196.
112. Mika, J., Korostynski, M., Kaminska, D., Wawrzczak-Bargiela, A., Osikowicz, M., Makuch, W., Przewlocki, R., Przewlocka, B., 2008. Interleukin-1alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model. Pain 138, 587-597.
113. Mika, J., Osikowicz, M., Makuch, W., Przewlocka, B., 2007. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur. J. Pharmacol. 560, 142-149.
114. Mika, J., Schafer, M.K., Makuch, W., Osikowicz, M., Weihe, E., Przewlocka, B., 2005. Activation of Microglial Complement Component C1q in the Rat Spinal Cord After Sciatic Nerve Injury and its Relation to Pain Behavior 11thWorld Congress on Pain.
115. Milligan, E.D., Sloane, E.M., Langer, S.J., Hughes, T.S., Jekich, B.M., Frank, M.G., Mahoney, J.H., Levkoff, L.H., Maier, S.F., Cruz, P.E., Flotte, T.R., Johnson, K.W., Mahoney, M.M., Chavez, R.A., Leinwand, L.A., Watkins, L.R., 2006. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 126, 294-308.
116. Milligan, E.D., Twining, C., Chacur, M., Biedenkapp, J., O'Connor, K., Poole, S., Tracey, K., Martin, D., Maier, S.F., Watkins, L.R., 2003. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 23, 1026-1040.
117. Milligan, E.D., O'Connor, K.A., Nguyen, K.T., Armstrong, C.B., Twining, C., Gaykema, R.P., Holguin, A., Martin, D., Maier, S.F., Watkins, L.R., 2001. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J. Neurosci. 21, 2808-2819.
118. Miyoshi, K., Obata, K., Kondo, T., Okamura, H., Noguchi, K., 2008. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J. Neurosci. 28, 12775-12787.
119. Mizuno, T., Kurotani, T., Komatsu, Y., Kawanokuchi, J., Kato, H., Mitsuma, N., Suzumura, A., 2004. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 46, 404-411.
120. Moore, K.W., O'Garra, A., de Waal Malefyt, R., Vieira, P., Mosmann, T.R., 1993. Interleukin-10. Review. Annu. Rev. Immunol. 11, 165-190.
121. Mor, D., Bembrick, A.L., Austin, P.J., Wyllie, P.M., Creber, N.J., Denyer, G.S., Keay, K.A., 2010. Anatomically specific patterns of glial activation in the periaqueductal gray of the sub-population of rats showing pain and disability following chronic constriction injury of the sciatic nerve. Neuroscience 166, 1167-1184.
122. Morgan, B.P., Gasque, P., 1996. Expression of complement in the brain: role in health and disease. Immunol. Today 17, 461-466.
123. Mosley, B., Urdal, D.L., Prickett, K.S., Larsen, A., Cosman, D., Conlon, P.J., Gillis, S., Dower, S.K., 1987. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J. Biol. Chem. 262, 2941-2944.
124. Murphy, P.G., Grondin, J., Altares, M., Richardson, P.M., 1995. Induction of interleukin-6 in axotomized sensory neurons. J. Neurosci. 15, 5130-5138.
125. Nakagawa, T., Wakamatsu, K., Zhang, N., Maeda, S., Minami, M., Satoh, M., Kaneko, S., 2007. Intrathecal administration of ATP produces long-lasting allodynia in rats: differentia mechanisms in the phase of the induction andmaintenance. Neuroscience 147, 445-455.
126. Nakajima, K., Kohsaka, S., 2001. Microglia: activation and their significance in the central nervous system. J. Biochem. 130, 169-175.
127. Nedergaard, M., 1994. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 25 (263), 1768-1771.
128. Neuner, P., Klosner, G., Schauer, E., Pourmojib, M., Macheiner, W., Grunwald, C., Knobler, R., Schwarz, A., Luger, T.A., Schwarz, T., 1994. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. Immunology 83, 262-267.
129. Niederberger, E., Manderscheid, C., Geisslinger, G., 2006. Different COX-independent effects of the COX-2 inhibitors etoricoxib and lumiracoxib. Biochem. Biophys. Res. Commun. 342, 940-948.
130. Niederberger, E., Tegeder, I., Schafer, C., Seegel, M., Grosch, S., Geisslinger, G., 2003. Opposite effects of rofecoxib on nuclear factor-kappaB and activating protein-1 activation. J. Pharmacol. Exp. Ther. 304, 1153-1160.
131. Obreja, O., Rathee, P.K., Lips, K.S., Distler, C., Kress, M., 2002. IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase and protein kinase C. FASEB J. 16, 1497-1503.
132. Ohtori, S., Miyagi, M., Eguchi, Y., Inoue, G., Orita, S., Ochiai, N., Kishida, S., Kuniyoshi, K., Nakamura, J., Aoki, Y., Ishikawa, T., Arai, G., Kamoda, H., Suzuki, M., Takaso, M., Furuya, T., Kubota, G., Sakuma, Y., Oikawa, Y., Toyone, T., Takahashi, K., 2012. Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur. Spine J. [Epub ahead of print].
133. Oka, T., Aou, S., Hori, T., 1993. Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats. Brain Res. 624, 61-68.
134. Oliet, S.H., Panatier, A., Piet, R., Mothet, J.P., Poulain, D.A., Theodosis, D.T., 2008. Neuron-glia interactions in the rat supraoptic nucleus. Prog. Brain Res. 170, 109-117.
135. O'Neill, L.A., 2006. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat. Rev. Drug Discov. 5, 549-563.
136. Opree, A., Kress, M., 2000. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J. Neurosci. 20, 6289-6293.
137. Osikowicz, M., Skup, M., Mika, J., Makuch, W., Czarkowska-Bauch, J., Przewlocka, B., 2009. Glial inhibitors influence the mRNA and protein levels of mGlu2/3, 5 and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain. Pain 147 (1-3), 175-186.
138. Osikowicz, M., Mika, J., Makuch, W., Przewlocka, B., 2008. Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain. Pain 139, 117-126.
139. Pasinetti, G.M., Johnson, S.A., Rozovsky, I., Lampert-Etchells, M., Morgan, D.G., Gordon, M.N., Morgan, T.E., Willoughby, D., Finch, C.E., 1992. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp. Neurol. 118, 117-125.
140. Pello, O.M., Martínez-Muñoz, L., Parrillas, V., Serrano, A., Rodríguez-Frade, J.M., Toro, M.J., Lucas, P., Monterrubio, M., Martínez-A, C., Mellado, M., 2008. Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation. Eur. J. Immunol. 38, 537-549.
141. Perera, L.P., Goldman, C.K., Waldmann, T.A., 1999. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J. Immunol. 162, 2606-2612.
142. Przewlocki, R., Machelska, H., Przewlocka, B., 1993. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci. 53, 1-5.
143. Przewlocki, R., Przewlocka, B., 2005. Opioids in neuropathic pain. Curr. Pharm. Des. 11, 3013-3025.
144. Qin, M., Wang, J.J., Cao, R., Zhang, H., Duan, L., Gao, B., Xiong, Y.F., Chen, L.W., Rao, Z. R., 2006. The lumbar spinal cord glial cells actively modulate subcutaneous formalin induced hyperalgesia in the rat. Neurosci. Res. 55, 442-450.
145. Queiroz, G., Gebicke-Haerter, P.J., Schobert, A., Starke, K., von Kügelgen, I., 1997. Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience 78, 1203-1208.
146. Racz, I., Nadal, X., Alferink, J., Baños, J.E., Rehnelt, J., Martín, M., Pintado, B., Gutierrez-Adan, A., Sanguino, E., Bellora, N., Manzanares, J., Zimmer, A., Maldonado, R., 2008. Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain. J. Neurosci. 28, 12136-12145.
147. Raghavendra, V., Tanga, F.Y., DeLeo, J.A., 2004a. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 29, 327-334.
148. Raghavendra, V., Tanga, F.Y., DeLeo, J.A., 2004b. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur. J. Neurosci. 20, 467-473.
149. Raghavendra, V., Tanga, F., Rutkowski, M.D., DeLeo, J.A., 2003. Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain 104, 655-664.
150. Relton, J.K., Rothwell, N.J., 1992. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29, 243-246.
151. Ribeiro, R.A., Vale, M.L., Ferreira, S.H., Cunha, F.Q., 2000. Analgesic effect of thalidomide on inflammatory pain. Eur. J. Pharmacol. 391, 97-103.
152. Richez, C., Blanco, P., Lagueny, A., Schaeverbeke, T., Dehais, J., 2005. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology 64, 1468-1470.
153. Rodriguez Parkitna, J., Korostynski, M., Kaminska-Chowaniec, D., Obara, I., Mika, J., Przewlocka, B., Przewlocki, R., 2006. Comparison of gene expression profiles in neuropathic and inflammatory pain. J. Physiol. Pharmacol. 57, 401-414.
154. Roh, D.H., Yoon, S.Y., Seo, H.S., Kang, S.Y., Han, H.J., Beitz, A.J., Lee, J.H., 2010. Intrathecal injection of carbenoxolone, a gap junction decoupler, attenuates the induction of below-level neuropathic pain after spinal cord injury in rats. Exp. Neurol. 224, 123-132.
155. Rolan, P., Hutchinson, M., Johnson, K., 2009. Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Rev. Expert Opin. Pharmacother. 10, 2897-2904.
156. Romero-Sandoval, A., Chai, N., Nutile-McMenemy, N., Deleo, J.A., 2008. A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res. 1219, 116-126.
157. Sacerdote, P., Franchi, S., Trovato, A.E., Valsecchi, A.E., Panerai, A.E., Colleoni, M., 2008. Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Neurosci. Lett. 436, 210-213.
158. Santos, A., Cabrales, A., Reyes, O., Gerónimo, H., Rodríguez, Y., Garay, H., Aurora-Arrieta, C., Silva, R., Guillén, G., 2008. Identification of an interleukin-15 antagonist peptide that binds to IL-15Rα. Biotecnología Aplicada 25, 320-324.
159. Sawada, M., Suzumura, A., Hosoya, H., Marunouchi, T., Nagatsu, T., 1999. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J. Neurochem. 72, 1466-1471.
160. Schafers, M., Svensson, C.I., Sommer, C., Sorkin, L.S., 2003. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 23, 2517-2521.
161. Scheinman, R.I., Cogswell, P.C., Lofquist, A.K., Baldwin Jr., A.S., 1995a. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270, 283-286.
162. Scheinman, R.I., Gualberto, A., Jewell, C.M., Cidlowski, J.A., Baldwin Jr., A.S., 1995b. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell Biol. 15, 943-953.
163. Schoeniger-Skinner, D.K., Ledeboer, A., Frank, M.G., Milligan, E.D., Poole, S., Martin, D., Maier, S.F., Watkins, L.R., 2007. Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain Behav. Immun. 21, 660-667.
164. Serrano, A., Paré,M.,McIntosh, F., Elmes, S.J.,Martino, G., Jomphe, C., Lessard, E., Lembo, P.M., Vaillancourt, F., Perkins, M.N., Cao, C.Q., 2010. Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain. Mol. Pain 6, 90.
165. Sfikakis, P.P., 2010. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr. Dir. Autoimmun. 11, 180-210.
166. Shen, Y., Li, R., McGeer, E.G., McGeer, P.L., 1997. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 769, 391-395.
167. Shi, J.Y., Liu, G.S., Liu, L.F., Kuo, S.M., Ton, C.H., Wen, Z.H., Tee, R., Chen, C.H., Huang, H.T., Chen, C.L., Chao, D., Tai, M.H., 2011. Glial cell line-derived neurotrophic factor gene transfer exerts protective effect on axons in sciatic nerve following constriction-induced peripheral nerve injury. Hum. Gene Ther. 22, 721-731.
168. Singh, J.A., Beg, S., Lopez-Olivo, M.A., 2010. Tocilizumab for rheumatoid arthritis. Cochrane Database Syst. Rev., 7.
169. Sommer, C., Schafers, M., Marziniak, M., Toyka, K.V., 2001. Etanercept reduces hyperalgesia in experimental painful neuropathy. J. Peripher. Nerv. Syst. 6, 67-72.
170. Sorkin, L.S., Xiao, W.H., Wagner, R., Myers, R.R., 1997. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81, 255-262.
171. Stoll, G., Jander, S., 1999. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58, 233-247.
172. Stuesse, S.L., Crisp, T., McBurney, D.L., Schechter, J.B., Lovell, J.A., Cruce, W.L., 2001. Neuropathic pain in aged rats: behavioral responses and astrocytic activation. Exp. Brain Res. 137, 219-227.
173. Sun, S., Cao, H., Han, M., Li, T.T., Pan, H.L., Zhao, Z.Q., Zhang, Y.Q., 2007. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis. Pain 129, 64-75.
174. Sun, T., Song, W.G., Fu, Z.J., Liu, Z.H., Liu, Y.M., Yao, S.L., 2006. Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. Br. J. Anaesth. 97, 553-555.
175. Suzuki, M., Kobayashi, H., Fujie, M., Nishida, T., Takigawa, M., Kanayama, N., Terao, T., 2002. Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells. J. Biol. Chem. 277, 8022-8032.
176. Suzumura, A., Ito, A., Yoshikawa, M., Sawada, M., 1999. Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS. Brain Res. 837, 203-212.
177. Suzumura, A., Sawada, M., Yamamoto, H., Marunouchi, T., 1993. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J. Immunol. 151, 2150-2215.
178. Sweitzer, S., Martin, D., DeLeo, J.A., 2001a. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103, 529-539.
179. Sweitzer, S.M., Schubert, P., DeLeo, J.A., 2001b. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J. Pharmacol. Exp. Ther. 297, 1210-1217.
180. Sweitzer, S.M., Colburn, R.W., Rutkowski, M., DeLeo, J.A., 1999. Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat. Brain Res. 829, 209-221.
181. Szczepanik, A.M., Wordliczek, J., Serednicki, W., Siedlar, M., Czupryna, A., 2004. Pentoxifylline does not affect nociception if administered postoperatively. Pol. J. Pharmacol. 56, 611-616.
182. Takeda, K., Muramatsu, M., Chikuma, T., Kato, T., 2009. Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain. J. Mol. Neurosci. 39, 380-390.
183. Tanga, F.Y., Raghavendra, V., DeLeo, J.A., 2004. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem. Int. 45, 397-407.
184. Tegeder, I., Niederberger, E., Israr, E., Guhring, H., Brune, K., Euchenhofer, C., Grosch, S., Geisslinger, G., 2001. Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J. 15, 2-4.
185. Terayama, R., Omura, S., Fujisawa, N., Yamaai, T., Ichikawa, H., Sugimoto, T., 2008. Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury. Neuroscience 153, 1245-1255.
186. Thacker, M.A., Clark, A.K., Bishop, T., Grist, J., Yip, P.K., Moon, L.D., Thompson, S.W., Marchand, F., McMahon, S.B., 2009. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur. J. Pain 13, 263-272.
187. Tidswell, M., LaRosa, S.P., 2011. Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis. Expert Rev. Anti. Infect. Ther. 9, 507-520.
188. Tikka, T., Fiebich, B.L., Goldsteins, G., Keinanen, R., Koistinaho, J., 2001. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21, 2580-2588.
189. Touzani, O., Boutin, H., Chuquet, J., Rothwell, N., 1999. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J. Neuroimmunol. 100, 203-215.
190. Tsuda, M., Kohro, Y., Yano, T., Tsujikawa, T., Kitano, J., Tozaki-Saitoh, H., Koyanagi, S., Ohdo, S., Ji, R.R., Salter, M.W., Inoue, K., 2011. JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain 134, 1127-1139.
191. Tsuda, M., Ueno, H., Kataoka, A., Tozaki-Saitoh, H., Inoue, K., 2008. Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. Glia 56, 378-386.
192. Tsuda, M., Mizokoshi, A., Shigemoto-Mogami, Y., Koizumi, S., Inoue, K., 2004. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45, 89-95.
193. Tunon de Lara, J.M., Okayama, Y., McEuen, A.R., Heusser, C.H., Church, M.K., Walls, A.F., 1994. Release and inactivation of interleukin-4 by mast cells. Ann. N.Y. Acad. Sci. 725, 50-58.
194. Twining, C.M., Sloane, E.M., Milligan, E.D., Chacur, M., Martin, D., Poole, S., Marsh, H., Maier, S.F., Watkins, L.R., 2004. Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats. Pain 110, 299-309.
195. Tzeng, S.F., Kahn, M., Liva, S., De Vellis, J., 1999. Tumor necrosis factor-alpha regulation of the Id gene family in astrocytes and microglia during CNS inflammatory injury. Glia 26, 139-152.
196. Vale, M.L., Marques, J.B., Moreira, C.A., Rocha, F.A., Ferreira, S.H., Poole, S., Cunha, F.Q., Ribeiro, R.A., 2003. Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J. Pharmacol. Exp. Ther. 304, 102-108.
197. Vanderah, T.W., Gardell, L.R., Burgess, S.E., Ibrahim, M., Dogrul, A., Zhong, C.M., Zhang, E.T., Malan Jr, T.P., Ossipov, M.H., Lai, J., Porreca, F., 2000. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J. Neurosci. 20, 7074-7079.
198. van Steenwinckel, J., Reaux-Le Goazigo, A., Pommier, B., Mauborgne, A., Dansereau, M.A., Kitabgi, P., Sarret, P., Pohl, M., Mélik Parsadaniantz, S., 2011. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J. Neurosci. 31, 5865-5875.
199. Vega-Avelaira, D., Moss, A., Fitzgerald, M., 2007. Age-related changes in the spinal cord microglial and astrocytic response profile to nerve injury. Brain Behav. Immun. 21, 617-623.
200. Verri Jr, W.A., Cunha, T.M., Parada, C.A., Poole, S., Liew, F.Y., Ferreira, S.H., Cunha, F.Q., 2007. Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18. Brain Behav. Immun. 21, 535-543.
201. von Jagow, B., Kohnen, T., 2008. Anterior optic neuropathy associated with adalimumab. Ophthalmologica 222, 292-294.
202. Wagner, R., DeLeo, J.A., Heckman, H.M., Myers, R.R., 1995. Peripheral nerve pathology following sciatic cryoneurolysis: relationship to neuropathic behaviors in the rat. Exp. Neurol. 133, 256-264.
203. Wang, R., King, T., Ossipov, M.H., Rossomando, A.J., Vanderah, T.W., Harvey, P., Cariani, P., Frank, E., Sah, D.W., Porreca, F., 2008a. Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury. Nat. Neurosci. 11, 488-496.
204. Wang, X.J., Kong, K.M., Qi, W.L., Ye, W.L., Song, P.S., 2005. Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury. Acta Pharmacol. Sin. 26, 934-942.
205. Wang, Z., Wang, J., Li, X., Yuan, Y., Fan, G., 2008b. Interleukin-1 beta of Red nucleus involved in the development of allodynia in spared nerve injury rats. Exp. Brain Res. 188, 379-384.
206. Watkins, L.R., Hutchinson, M.R., Rice, K.C., Maier, S.F., 2009. The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Review. Trends Pharmacol. Sci. 30, 581-591.
207. Watkins, L.R., Hutchinson, M.R., Ledeboer, A., Wieseler-Frank, J., Milligan, E.D., Maier, S.F., 2007. Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav. Immun. 21, 131-146.
208. Watkins, L.R., Hutchinson, M.R., Johnston, I.N., Maier, S.F., 2005. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci. 28, 661-669.
209. Watkins, L.R., Maier, S.F., 2003. Glia: a novel drug discovery target for clinical pain. Nat. Rev. Drug Discovery 2, 973-985.
210. Watkins, L.R., Milligan, E.D., Maier, S.F., 2003. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv. Exp. Med. Biol. 521, 1-21.
211. Watkins, L.R., Milligan, E.D., Maier, S.F., 2001. Spinal cord glia: new players in pain. Pain 93, 201-205.
212. Wei, F.,Guo, W., Zou, S., Ren, K.,Dubner, R., 2008. Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J. Neurosci. 28, 10482-10495.
213. Wei, X.H., Zang, Y., Wu, C.Y., Xu, J.T., Xin, W.J., Liu, X.G., 2007. Peri-sciatic administration of recombinant rat TNF-alpha induces mechanical allodynia via upregulation of TNF-alpha in dorsal root ganglia and in spinal dorsal horn: the role of NF-kappa B pathway. Exp. Neurol. 205, 471-484.
214. Weihe, E., Nohr, D., Michel, S., Muller, S., Zentel, H.J., Fink, T., Krekel, J., 1991. Molecular anatomy of the neuro-immune connection. Int. J. Neurosci. 59, 1-23.
215. Wen, Y.R., Suter, M.R., Kawasaki, Y.,Huang, J., Pertin, M., Kohno, T., Berde, C.B.,Decosterd, I., Ji, R.R., 2007. Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen- activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology 107, 312-321.
216. Wen Tao, Z., Gu Yang, T., Ying, R., Mao Cai, W., Lin, L., Chi Miao, L., Peng, H., Joa Qin, C., 2011. The antinociceptive efficacy of HWTX-I epidurally administered in rheumatoid arthritis rats. Int. J. Sports Med. 32, 869-874.
217. White, F.A., Jung, H., Miller, R.J., 2007. Chemokines and the pathophysiology of neuropathic pain. Proc. Nat. Acad. Sci. U.S.A. 18 (104), 20151-20158.
218. Winkelstein, B.A., Rutkowski, M.D., Sweitzer, S.M., Pahl, J.L., DeLeo, J.A., 2001. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J. Comp. Neurol. 439, 127-139.
219. Woolf, C.J., Mannion, R.J., 1999. Neuropathic pain: etiology, symptoms, mechanisms, and management. Lancet 353, 1959-1964.
220. Wordliczek, J., Szczepanik, A.M., Banach, M., Turchan, J., Zembala, M., Siedlar, M., Przewlocki, R., Serednicki, W., Przewlocka, B., 2000. The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. Life Sci. 66, 1155-1164.
221. Wu, D.C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.K., Ischiropoulos, H., Przedborski, S., 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763-1771.
222. Wu, F., Chakravarti, S., 2007. Differential expression of inflammatory and fibrogenic genes and their regulation by NF-kappaB inhibition in a mouse model of chronic colitis. J. Immunol. 179, 6988-7000.
223. Yamakawa, I., Kojima, H., Terashima, T., Katagi, M., Oi, J., Urabe, H., Sanada, M., Kawai, H., Chan, L., Yasuda, H., Maegawa, H., Kimura, H., 2011. Inactivation of TNFα ameliorates diabetic neuropathy in mice. Am. J. Physiol. Endocrinol. Metab. 301, 844-852.
224. Yamauchi, K., Osuka, K., Takayasu, M., Usuda, N., Nakazawa, A., Nakahara, N., Yoshida, M., Aoshima, C., Hara, M., Yoshida, J., 2006. Activation of JAK/STAT signalling in neurons following spinal cord injury in mice. J. Neurochem. 96, 1060-1070.
225. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T., Koistinaho, J., 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Nat. Acad. Sci. U.S.A. 95, 15769-15774.
226. Zanjani, T.M., Sabetkasaei, M., Mosaffa, N., Manaheji, H., Labibi, F., Farokhi, B., 2006. Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. Eur. J. Pharmacol. 538, 66-72.
227. Zhang, R., Liu, B., Wang, L., Ren, K., Qiao, J.T., Berman, B.M., Lao, L., 2005. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 118, 125-136.
228. Zhang, J., Li, H., Liu, B., Brull, S.J., 2002. Acute topical application of tumor necrosis factor alpha evokes protein kinase A-dependent responses in rat sensory neurons. J. Neurophysiol. 88, 1387-1392.
229. Zhuang, Z.Y., Kawasaki, Y., Tan, P.H., Wen, Y.R., Huang, J., Ji, R.R., 2007. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav. Immun. 21, 642-651.
230. Zhuang, Z.Y., Gerner, P., Woolf, C.J., Ji, R.R., 2005. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114, 149-159.
231. Zhuang, Z.Y., Wen, Y.R., Zhang, D.R., Borsello, T., Bonny, C., Strichartz, G.R., Decosterd, I., Ji, R.R., 2006. A peptide c- Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 26, 3551-3560.
232. Zündorf, G., Kahlert, S., Reiser, G., 2007. Gap-junction blocker carbenoxolone differentially enhances NMDA-induced cell death in hippocampal neurons and astrocytes in co-culture. J. Neurochem. 102, 508-521.